Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.450
-0.181 (-6.88%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Alaunos Therapeutics Employees
Alaunos Therapeutics had 1 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$10,000
Profits / Employee
-$4,679,000
Market Cap
3.92M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
TCRT News
- 1 year ago - Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives - GlobeNewsWire
- 1 year ago - Top 5 Health Care Stocks That Could Blast Off This Month - Allakos (NASDAQ:ALLK), BioLife Solns (NASDAQ:BLFS) - Benzinga
- 1 year ago - Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies - GlobeNewsWire
- 2 years ago - Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 2 years ago - Alaunos Therapeutics, Inc. (TCRT) Q1 2023 Earnings Call Transcript - Seeking Alpha
- 2 years ago - Alaunos Therapeutics Reports First Quarter 2023 Financial Results - GlobeNewsWire
- 2 years ago - Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023 - GlobeNewsWire